These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 22186325)

  • 1. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
    Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
    Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and in vitro evaluation of ofloxacin-ethocel controlled release matrix tablets prepared by wet granulation method: influence of co-excipients on drug release rates.
    Shah S; Shah K; Jan SU; Ahmad K; Rehman A; Hussain A; Khan GM
    Pak J Pharm Sci; 2011 Jul; 24(3):255-61. PubMed ID: 21715257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU; Shah KU; Rehman A; Khan GM
    Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent.
    Khan KA; Khan GM; Zeeshan Danish M; Akhlaq ; Khan H; Rehman F; Mehsud S
    Int J Pharm; 2015 Dec; 496(2):759-65. PubMed ID: 26545310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
    Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA
    Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Preparation and evaluation of various parameters of controlled release matrices of losartan potassium using polymers combination.
    Khan KA; Khan GM; Shah KU; Niazi ZR; Khan H; Ahmad A; -Ur-Rehman F; Shah PA; Ullah A; Tahir M; Jan SU
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2231-2237. PubMed ID: 33832895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
    Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
    Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M.
    Lamoudi L; Chaumeil JC; Daoud K
    Drug Dev Ind Pharm; 2012 May; 38(5):515-20. PubMed ID: 21978389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J; Ibrić S; Betz G; Đurić Z
    Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple and rapid approach to evaluate the in vitro in vivo role of release controlling agent ethyl cellulose ether derivative polymer.
    Akhlaq M; Khan GM; Jan SU; Wahab A; Hussain A; Nawaz A; Abdelkader H
    Pak J Pharm Sci; 2014 Nov; 27(6):1789-98. PubMed ID: 25362603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of excipients on the release kinetics of diclofenac sodium and papaverine hydrochloride from composed tablets.
    Kasperek R; Trebacz H; Zimmer Ł; Poleszak E
    Acta Pol Pharm; 2014; 71(3):439-49. PubMed ID: 25265824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development and in vitro evaluation of theophylline microcapsules.
    Ahmad M; Akhtar N; Murtaza G; Hussain SW
    Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
    Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
    Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.